Finding 1101067 (2024-004)

Significant Deficiency
Requirement
C
Questioned Costs
-
Year
2024
Accepted
2025-02-27
Audit: 344056
Organization: Marymount University (VA)

AI Summary

  • Core Issue: Four out of five reimbursement requests lacked proper review and approval documentation.
  • Impacted Requirements: Payments must be reviewed and authorized before submission, as per federal guidelines.
  • Recommended Follow-Up: The University should enhance internal controls to ensure reviews are conducted by someone other than the person making the reimbursement request.

Finding Text

Criteria or Specific Requirement: For recipients of research and development grants, payment methods must minimize the time elapsing between the transfer of funds from the Federal agency or the pass-through entity and the disbursement of funds by the recipient or subrecipient regardless of whether the payment is made by electronic funds transfer or by other means. When the reimbursement method is used, the Federal agency or pass-through entity must make payment within 30 calendar days after receipt of the payment request unless the Federal agency or pass-through entity reasonably believes the request to be improper (2 CFR 200.305(b)(3)). The University must develop its own control activities. Requests for reimbursement are to be reviewed and authorized prior to submission by reviewing supporting documents/schedules/reports to ensure amounts have been paid with the University's funds prior to the reimbursement request. Condition/Context: During our testing of 5 reimbursement requests made during the fiscal year, we noted 4 instances that did not include documentation of review and approval by a representative of the University. Questioned Costs: None. Cause: The University’s internal controls did not include a control for review and approval by an individual other than the person performing the drawdown calculation and request from the federal agency. Effect: Incorrect drawdown requests could be made of the federal agency. Repeat Finding: No. Recommendation: We recommend the University review its internal controls around the reimbursement process for all federal grants to ensure the necessary review and approval controls are in place and performed by an individual other than the one performing the drawdown calculation and request from the federal agency. Views of Responsible Officials: Please refer to the attached corrective action plan.

Categories

Subrecipient Monitoring Cash Management

Other Findings in this Audit

  • 524608 2024-002
    Significant Deficiency Repeat
  • 524609 2024-003
    Significant Deficiency Repeat
  • 524610 2024-002
    Significant Deficiency Repeat
  • 524611 2024-003
    Significant Deficiency Repeat
  • 524612 2024-002
    Significant Deficiency Repeat
  • 524613 2024-003
    Significant Deficiency Repeat
  • 524614 2024-002
    Significant Deficiency Repeat
  • 524615 2024-003
    Significant Deficiency Repeat
  • 524616 2024-004
    Significant Deficiency
  • 524617 2024-004
    Significant Deficiency
  • 524618 2024-004
    Significant Deficiency
  • 524619 2024-004
    Significant Deficiency
  • 524620 2024-004
    Significant Deficiency
  • 524621 2024-004
    Significant Deficiency
  • 524622 2024-004
    Significant Deficiency
  • 524623 2024-004
    Significant Deficiency
  • 524624 2024-004
    Significant Deficiency
  • 524625 2024-004
    Significant Deficiency
  • 524626 2024-002
    Significant Deficiency Repeat
  • 524627 2024-003
    Significant Deficiency Repeat
  • 1101050 2024-002
    Significant Deficiency Repeat
  • 1101051 2024-003
    Significant Deficiency Repeat
  • 1101052 2024-002
    Significant Deficiency Repeat
  • 1101053 2024-003
    Significant Deficiency Repeat
  • 1101054 2024-002
    Significant Deficiency Repeat
  • 1101055 2024-003
    Significant Deficiency Repeat
  • 1101056 2024-002
    Significant Deficiency Repeat
  • 1101057 2024-003
    Significant Deficiency Repeat
  • 1101058 2024-004
    Significant Deficiency
  • 1101059 2024-004
    Significant Deficiency
  • 1101060 2024-004
    Significant Deficiency
  • 1101061 2024-004
    Significant Deficiency
  • 1101062 2024-004
    Significant Deficiency
  • 1101063 2024-004
    Significant Deficiency
  • 1101064 2024-004
    Significant Deficiency
  • 1101065 2024-004
    Significant Deficiency
  • 1101066 2024-004
    Significant Deficiency
  • 1101068 2024-002
    Significant Deficiency Repeat
  • 1101069 2024-003
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
84.268 Federal Direct Student Loans $36.12M
84.063 Federal Pell Grant Program $3.02M
84.031 Higher Education Institutional Aid $429,524
84.038 Federal Perkins Loan Program_federal Capital Contributions $382,363
93.732 Mental and Behavioral Health Education and Training Grants $300,921
12.905 Cybersecurity Core Curriculum $258,163
84.007 Federal Supplemental Educational Opportunity Grants $217,325
84.033 Federal Work-Study Program $211,296
93.761 Evidence-Based Falls Prevention Programs Financed Solely by Prevention and Public Health Funds (pphf) $204,377
47.076 Stem Education (formerly Education and Human Resources) $98,351
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $84,425
47.084 Nsf Technology, Innovation, and Partnerships $45,398
17.289 Community Project Funding/congressionally Directed Spending $30,169
12.903 Gencyber Grants Program $29,244
47.070 Computer and Information Science and Engineering $6,994